Florida-based VITAS Healthcare is taking a more “relationship-based” approach to growth in 2025. The Chemed Corp. (NYSE: CHE) subsidiary’s expanding geographic footprint in Florida has been heavily fueled through organic growth. The prospect of acquisitions is playing a larger role, with the hospice company recently setting its sights on expansion across 12 states. VITAS has […]
VITAS Healthcare, a subsidiary of Chemed Corp. (NYSE: CHE), is reaping the benefits of this recent $85 million purchase of Covenant Health and Community Services hospice business, along with one assisted living facility location. The deal is structured as an asset purchase, which allows the buyer to assume liability for assets included in the transaction. […]
Chemed Corp. (NYSE: CHE) subsidiary VITAS Healthcare is ramping up its strategic growth plans in both hospice and palliative care amid rising demand for these services. VITAS earlier this month completed its $85 million acquisition of Covenant Health and Community Services’ hospice operations and one assisted living facility location. Announced in March, the deal marked […]
VITAS Healthcare, a subsidiary of Chemed Corp. (NYSE: CHE), has completed its $85 million acquisition of Covenant Health and Community Services’ hospice operations and one assisted living facility location. The deal is structured as an asset purchase, which allows the buyer to assume liability for assets included in the transaction. It also brings VITAS into […]
In case you missed it, Hospice News has launched a new specialty publication for palliative care professionals. You can subscribe to Palliative Care News here: Subscribe today! VITAS Healthcare Corporation has penned an agreement to acquire Covenant Health and Community Services’ hospice operations and one of its assisted living facility locations for $85 million. The […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
